Cornelia Marty
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 4
- Glycosylation and Glycoproteins Research 2
- Angiogenesis and VEGF in Cancer 2
- Advanced biosensing and bioanalysis techniques 2
-
- Monoclonal and Polyclonal Antibodies Research 6
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Reto A. Schwendener (9 shared papers)Kurt Ballmer‐Hofer (8 shared papers)B Odermatt (2 shared papers)Carlos Garcı́a-Echeverrı́a (1 shared paper)Herbert Schott (3 shared papers)Francis C. Szoka (1 shared paper)Shlomo Nir (1 shared paper)Rom E. Eliaz (1 shared paper)
- Journals
- British Journal of Cancer (2 papers)Oncology Reports (1 paper)Protein Expression and Purification (1 paper)Bioconjugate Chemistry (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Cornelia Marty
12 papers receiving 1.4k citations
Cornelia Marty's Hit Papers
Peers
Comparison fields: 5 of 91
- Immunology 467
- Biomaterials 218
- Molecular Biology 817
- Oncology 276
- Microbiology 61
Countries citing papers authored by Cornelia Marty
This map shows the geographic impact of Cornelia Marty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia Marty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia Marty more than expected).
Fields of papers citing papers by Cornelia Marty
This network shows the impact of papers produced by Cornelia Marty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia Marty. The network helps show where Cornelia Marty may publish in the future.
Co-authors
The 20 scholars most cited alongside Cornelia Marty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach Hit paper breakdown → | 2006 | 525 |
| 2 | 2003 | 361 | |
| 3 | 2004 | 137 | |
| 4 | 2004 | 100 | |
| 5 | 2005 | 77 | |
| 6 | 2002 | 66 | |
| 7 | 2005 | 35 | |
| 8 | 2001 | 30 | |
| 9 | 2004 | 25 | |
| 10 | Metastases of human tumor xenografts in nude mice. | 1984 | 19 |
| 11 | Targeting human cancer cells with VEGF receptor-2-directed liposomes. | 2005 | 18 |
| 12 | 2007 | 11 |
About Cornelia Marty
Cornelia Marty is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Biomaterials, Immunology and Oncology, having authored 12 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), RNA Interference and Gene Delivery (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Glycosylation and Glycoproteins Research (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Cell Adhesion Molecules Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Immunology (467 citations), Biomaterials (218 citations), Molecular Biology (817 citations), Oncology (276 citations) and Microbiology (61 citations). Cornelia Marty has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Reto A. Schwendener, Kurt Ballmer‐Hofer, B Odermatt, Carlos Garcı́a-Echeverrı́a, Herbert Schott, Francis C. Szoka, Shlomo Nir, Rom E. Eliaz, R Klemenz and Roger Alberto. Their work appears in journals such as British Journal of Cancer, Oncology Reports, Protein Expression and Purification, Bioconjugate Chemistry and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.